Tactile Systems Technology, Inc. Provides Sales Guidance for the Fourth Quarter and Full Year Ended December 31, 2016
January 09, 2017 at 12:30 pm
Share
Tactile Systems Technology, Inc. provided sales guidance for the fourth quarter and full year ended December 31, 2016. For the quarter, total revenue is expected to be in the range of $26.9 million to $27.9 million, representing growth of approximately 27% to 32% year-over-year.
Full year 2016 revenue is expected to be in the range of $83.0 million to $84.0 million, representing growth of approximately 32% to 34% year-over-year.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
TACTILE SYSTEMS TECHNOLOGY, INC. 
